Aandelen in “Productie van wapens en munitie”

Aandeel Datum Koers Evolutie
vlag Perspective Therapeutics Inc 16/03 5,220 USD
+4,40% 		+4,40%

Nieuws over “Productie van wapens en munitie”

12/03 · INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights · Persbericht

12/03 · INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights · Persbericht

12/03 · Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO · Persbericht

11/03 · INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 · Persbericht

9/03 · INOVIO to Participate in Upcoming Scientific Conferences · Persbericht

6/03 · INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026 · Persbericht

5/03 · Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO · Persbericht

5/03 · INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 · Persbericht

4/03 · LEVI & KORSINSKY, LLP: INO SHARES DECLINE 24% AS FDA REVIEW CLASSIFICATION REVEALS ALLEGED REGULATORY SETBACK · Persbericht

4/03 · INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) · Persbericht

2/03 · Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

27/02 · INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 · Persbericht

26/02 · Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO · Persbericht

25/02 · LEVI & KORSINSKY, LLP: SECTION 10(B) AND RULE 10B-5 CLAIMS ASSERTED IN INOVIO PHARMACEUTICALS SECURITIES LITIGATION · Persbericht

20/02 · INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 · Persbericht

20/02 · Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO · Persbericht

18/02 · Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact Levi & Korsinsky · Persbericht

12/02 · Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO · Persbericht

12/02 · INOVIO to Participate in Upcoming Scientific and Investor Conferences · Persbericht

11/02 · INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 · Persbericht

29/12 · FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) · Persbericht

Mijn selecties